Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE): a Prospective Cohort Study

NCT06277531 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT06277531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE): a Prospective Cohort Study
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2024
Completion date
July 1, 2026
Enrollment
99 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer, biliary stricture, pancreas cancer